Education
About Us
Working with TipRanks
Follow Us
Eli Lilly And Company (LLY)
:LLY
Total Valuation
Eli Lilly & Co has a market cap or net worth of $696.62B. The enterprise value is $737.86B.
Market Cap$696.62B
Enterprise Value$737.86B
Share Statistics
Eli Lilly & Co has 946,456,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding946,456,800
Owned by Insiders10.27%
Owned by Institutions26.78%
Financial Efficiency
Eli Lilly & Co’s return on equity (ROE) is 0.75 and return on invested capital (ROIC) is 26.36%.
Return on Equity (ROE)0.75
Return on Assets (ROA)0.13
Return on Invested Capital (ROIC)26.36%
Return on Capital Employed (ROCE)0.35
Revenue Per Employee958.36K
Profits Per Employee225.32K
Employee Count47,000
Asset Turnover0.57
Inventory Turnover1.11
Valuation Ratios
The current PE Ratio of Eli Lilly & Co is 46.1. Eli Lilly & Co’s PEG ratio is ―.
PE Ratio46.1
PS Ratio―
PB Ratio―
Price to Fair Value48.99
Price to FCF―
Price to Operating Cash Flow54.22
PEG Ratio―
Income Statement
In the last 12 months, Eli Lilly & Co had revenue of 45.04B and earned 10.59B in profits. Earnings per share was 11.76.
Revenue45.04B
Gross Profit36.62B
Operating Income17.50B
Pretax Income12.68B
Net Income10.59B
EBITDA15.23B
Earnings Per Share (EPS)11.76
Cash Flow
In the last 12 months, operating cash flow was 10.94B and capital expenditures -10.99B, giving a free cash flow of -50.20M billion.
Operating Cash Flow10.94B
Free Cash Flow-50.20M
Free Cash Flow per Share-0.05
Dividends & Yields
Eli Lilly & Co pays an annual dividend of $1.5, resulting in a dividend yield of 0.79%
Dividend Per Share$1.5
Dividend Yield0.79%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.70
52-Week Price Change-22.04%
50-Day Moving Average749.29
200-Day Moving Average785.27
Relative Strength Index (RSI)53.56
Average Volume (3m)5.72M
Important Dates
Eli Lilly & Co upcoming earnings date is Oct 30, 2025, Before Open (Confirmed).
Last Earnings DateAug 7, 2025
Next Earnings DateOct 30, 2025
Ex-Dividend DateAug 15, 2025
Financial Position
Eli Lilly & Co as a current ratio of 1.15, with Debt / Equity ratio of 187.05%
Current Ratio1.15
Quick Ratio0.89
Debt to Market Cap0.05
Net Debt to EBITDA1.99
Interest Coverage Ratio22.42
Taxes
In the past 12 months, Eli Lilly & Co has paid 2.09B in taxes.
Income Tax2.09B
Effective Tax Rate0.16
Enterprise Valuation
Eli Lilly & Co EV to EBITDA ratio is 47.65, with an EV/FCF ratio of 1.75K.
EV to Sales16.11
EV to EBITDA47.65
EV to Free Cash Flow1.75K
EV to Operating Cash Flow82.29
Balance Sheet
Eli Lilly & Co has $3.55B in cash and marketable securities with $39.90B in debt, giving a net cash position of $36.36B billion.
Cash & Marketable Securities$3.55B
Total Debt$39.90B
Net Cash$36.36B
Net Cash Per Share$38.41
Tangible Book Value Per Share$2.59
Margins
Gross margin is 82.87%, with operating margin of 38.86%, and net profit margin of 23.51%.
Gross Margin82.87%
Operating Margin38.86%
Pretax Margin28.15%
Net Profit Margin23.51%
EBITDA Margin33.81%
EBIT Margin29.88%
Analyst Forecast
The average price target for Eli Lilly & Co is $910.61, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$910.61
Price Target Upside23.72% Upside
Analyst ConsensusModerate Buy
Analyst Count23
Revenue Growth Forecast36.83%
EPS Growth Forecast88.21%